HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hideyuki Saya Selected Research
Hideyuki Saya Research Topics
Disease
154
Neoplasms (Cancer)
04/2024 - 02/2002
24
Glioma (Gliomas)
03/2024 - 05/2003
19
Glioblastoma (Glioblastoma Multiforme)
03/2024 - 10/2003
19
Neoplasm Metastasis (Metastasis)
03/2022 - 02/2007
16
Carcinogenesis
10/2021 - 12/2003
13
Breast Neoplasms (Breast Cancer)
10/2021 - 07/2008
11
Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 08/2007
10
Stomach Neoplasms (Stomach Cancer)
12/2023 - 06/2008
9
Cholangiocarcinoma
12/2022 - 03/2010
7
Brain Neoplasms (Brain Tumor)
01/2019 - 10/2009
6
Inflammation (Inflammations)
10/2021 - 09/2013
6
Melanoma (Melanoma, Malignant)
06/2021 - 11/2013
6
Squamous Cell Carcinoma of Head and Neck
11/2019 - 02/2007
6
Neurofibromatosis 1 (Neurofibromatosis Type I)
08/2010 - 03/2003
5
Hypoxia (Hypoxemia)
02/2024 - 11/2002
5
Carcinoma (Carcinomatosis)
01/2023 - 01/2012
5
Warts (Wart)
05/2012 - 10/2002
4
Adenocarcinoma
01/2023 - 09/2016
4
Prostatic Neoplasms (Prostate Cancer)
01/2023 - 08/2007
4
COVID-19
12/2022 - 01/2021
4
Astrocytoma (Pilocytic Astrocytoma)
10/2019 - 10/2003
4
Leukemia
01/2019 - 10/2009
3
Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 04/2019
3
Esophageal Squamous Cell Carcinoma
06/2023 - 01/2023
3
Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 04/2005
3
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2013
3
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2016
3
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2011
3
Pneumonia (Pneumonitis)
01/2021 - 01/2013
3
Fibrosis (Cirrhosis)
05/2018 - 02/2010
3
Metaplasia
02/2017 - 10/2013
3
Retinoblastoma (Glioblastoma, Retinal)
06/2012 - 11/2006
2
Ascites
12/2023 - 01/2022
2
Infections
06/2023 - 12/2022
Drug/Important Bio-Agent (IBA)
22
Proteins (Proteins, Gene)
FDA Link
12/2022 - 07/2003
15
Phosphotransferases (Kinase)
IBA
10/2021 - 12/2003
14
Sulfasalazine (Azulfidine)
FDA Link
Generic
03/2021 - 10/2013
13
Protein Isoforms (Isoforms)
IBA
07/2022 - 01/2012
12
Glutathione (Reduced Glutathione)
IBA
01/2020 - 01/2012
12
Cystine (L-Cystine)
IBA
11/2019 - 06/2012
10
Biomarkers (Surrogate Marker)
IBA
04/2024 - 05/2016
10
Enzymes
IBA
01/2023 - 01/2005
10
DNA (Deoxyribonucleic Acid)
IBA
05/2022 - 05/2002
10
Cisplatin (Platino)
FDA Link
Generic
03/2021 - 01/2016
10
Glutamic Acid (Glutamate)
FDA Link
11/2019 - 04/2015
9
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2017 - 03/2011
8
Antioxidants
IBA
01/2021 - 03/2012
8
Small Interfering RNA (siRNA)
IBA
12/2018 - 07/2008
8
ErbB Receptors (EGF Receptor)
IBA
12/2018 - 10/2003
7
Transcription Factors (Transcription Factor)
IBA
01/2021 - 08/2010
7
Cadherins (E-Cadherin)
IBA
01/2021 - 07/2008
7
Messenger RNA (mRNA)
IBA
01/2020 - 03/2010
6
Ligands
IBA
10/2021 - 01/2014
6
Neurofibromin 1 (Neurofibromin)
IBA
01/2018 - 07/2003
5
Epithelial Cell Adhesion Molecule
IBA
12/2023 - 11/2011
5
Glucose (Dextrose)
FDA Link
Generic
01/2022 - 03/2012
5
Paclitaxel (Taxol)
FDA Link
Generic
01/2018 - 02/2002
5
Hyaluronic Acid (Hyaluronan)
IBA
01/2017 - 08/2003
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2015 - 06/2008
5
Cyclin-Dependent Kinase Inhibitor p16
IBA
06/2012 - 11/2006
4
Antineoplastic Agents (Antineoplastics)
IBA
04/2024 - 08/2004
4
Antibodies
IBA
06/2023 - 01/2016
4
Amino Acids
FDA Link
01/2023 - 10/2012
4
Cytokines
IBA
10/2021 - 05/2009
4
Celecoxib (Celebrex)
FDA Link
01/2021 - 01/2017
4
Antiporters
IBA
11/2019 - 09/2018
4
Trastuzumab (Herceptin)
FDA Link
01/2018 - 05/2008
4
Monoclonal Antibodies
IBA
01/2016 - 08/2003
3
Circulating Tumor DNA
IBA
06/2023 - 01/2023
3
Gemcitabine
FDA Link
01/2023 - 03/2021
3
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2017
3
Neutralizing Antibodies
IBA
12/2022 - 01/2021
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
03/2022 - 12/2017
3
Oxygen (Dioxygen)
IBA
01/2022 - 01/2018
3
Periostin
IBA
06/2021 - 01/2015
3
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
01/2021 - 01/2017
3
Lipids
IBA
01/2021 - 10/2012
3
Micelles
IBA
10/2019 - 01/2016
3
Histones (Histone)
IBA
01/2019 - 05/2013
3
Epidermal Growth Factor (EGF)
IBA
12/2018 - 01/2014
3
human ERBB2 protein
IBA
07/2018 - 06/2012
3
Indicators and Reagents (Reagents)
IBA
01/2018 - 05/2016
3
spasmolytic polypeptide
IBA
02/2017 - 10/2013
3
Dinoprostone (PGE2)
FDA Link
03/2016 - 03/2010
3
Progesterone Receptors (Progesterone Receptor)
IBA
12/2015 - 06/2012
3
Estrogen Receptors
IBA
12/2015 - 06/2012
3
Pyruvate Kinase
IBA
08/2014 - 03/2012
3
GTPase-Activating Proteins (GTPase-Activating Protein)
IBA
11/2005 - 07/2003
3
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
08/2005 - 10/2002
2
protoporphyrin IX
IBA
03/2024 - 01/2021
2
Androgen Receptors (Androgen Receptor)
IBA
10/2023 - 08/2007
2
Boron
IBA
01/2023 - 01/2012
Therapy/Procedure
40
Therapeutics
04/2024 - 05/2003
20
Drug Therapy (Chemotherapy)
02/2024 - 07/2009
6
Transplantation
03/2022 - 02/2010
5
Radiotherapy
01/2023 - 01/2016
4
Aftercare (After-Treatment)
01/2016 - 04/2005
3
Immunotherapy
04/2023 - 01/2018
2
Neoadjuvant Therapy
02/2024 - 06/2023
2
Castration
01/2023 - 05/2016